Evidence map›Paper›PMID 32206804›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Influenza Challenge Models: Ready for Prime Time?

David I Bernstein, Robert L Atmar, Daniel F Hoft

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

David I BernsteinCincinnati Children's Hospital, University of Cincinnati, Cincinnati, Ohio, USA.
Robert L AtmarDepartments of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Daniel F HoftDivision of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA.

Funding

Vaccine and Treatment Evaluation Unit at Saint Louis University - DMID 20-0034UM1AI148685 · NIAID · SAINT LOUIS UNIVERSITY · PI Daniel F. Hoft · 2020 to 2026
$34.6M
NIAID NIH HHS UM1 AI148685
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Influenza A virusInfluenza, HumanOrthomyxoviridae InfectionsHealthy VolunteersHumansInfluenza A Virus, H3N2 Subtype

Identifiers

PMID32206804
PMCPMC8599831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.